Literature DB >> 22339717

Risk factors for chronic pouchitis after ileal pouch-anal anastomosis: a prospective cohort study.

E Hashavia1, I Dotan, M Rabau, J M Klausner, Z Halpern, H Tulchinsky.   

Abstract

AIM: The association between various demographic, clinical and pathological parameters and the evolution of chronic pouchitis was evaluated.
METHOD: All ulcerative colitis patients who underwent ileal pouch anal anastomosis (1981-2009) were followed prospectively in a comprehensive pouch clinic. We examined risk factors including the presence of appendiceal inflammation and backwash ileitis in the colonic specimen, gender, ethnicity, age at disease onset, disease duration, extent of colitis, presence of extraintestinal manifestations (e.g. primary sclerosing cholangitis), family history of inflammatory bowel disease, indication for surgery, medical treatment, age at operation, staged procedure, diverting ileostomy and length of follow-up. Univariate analysis was performed on all risk factors followed by logistic regression analysis.
RESULTS: The 201 enrolled patients (106 women, age at surgery 35 ± 15 years) were followed for a mean of 108 months. One hundred and thirty-eight (69%) had either a normal pouch or episodes of acute pouchitis and 63 (31%) developed chronic pouchitis. On univariate analysis the presence of an ileostomy (P = 0.017), pancolitis (P = 0.008), shorter disease duration (P = 0.04) and longer follow-up (P = 0.01) were identified as risk factors for chronic pouchitis. Multivariate analysis showed that patients with pancolitis (OR 3.26, 95% CI 1.20-8.85) and longer follow-up (OR 1.09, 95% CI 1.01-1.18) were more likely to develop chronic pouchitis. There was also an association to disease duration but this did not reach a level of significance.
CONCLUSIONS: Pancolitis and longer follow-up are directly related to the development of chronic pouchitis.
© 2012 The Authors. Colorectal Disease © 2012 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2012        PMID: 22339717     DOI: 10.1111/j.1463-1318.2012.02993.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  17 in total

1.  Update on the pathogenesis and management of pouchitis.

Authors:  Saleem Chowdhry; Jeffry A Katz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

Review 2.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

3.  FK506-Binding Protein 5 mRNA Levels in Ileal Mucosa Are Associated with Pouchitis in Patients with Ulcerative Colitis.

Authors:  Toshimitsu Araki; Mikio Kawamura; Koji Tanaka; Yoshiki Okita; Hiroyuki Fujikawa; Keiichi Uchida; Yuji Toiyama; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Dig Dis Sci       Date:  2015-01-18       Impact factor: 3.199

4.  Inflammation of the rectal remnant endangers the outcome of ileal pouch-anal anastomosis: a case-control study.

Authors:  Jan P Frese; Jörn Gröne; Johannes C Lauscher; Martin E Kreis; Benjamin Weixler; Katharina Beyer; Claudia Seifarth
Journal:  Int J Colorectal Dis       Date:  2022-06-17       Impact factor: 2.796

5.  Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients.

Authors:  Maia Kayal; Michael Plietz; Anam Rizvi; Marlana Radcliffe; Alexa Riggs; Clara Yzet; Emily Tixier; Parth Trivedi; Ryan C Ungaro; Sergey Khaitov; Patricia Sylla; Alexander Greenstein; Jean Frederic Colombel; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

6.  Male Gender Is Associated with a High Risk for Chronic Antibiotic-Refractory Pouchitis and Ileal Pouch Anastomotic Sinus.

Authors:  Xian-Rui Wu; Jean Ashburn; Feza H Remzi; Yi Li; Hagar Fass; Bo Shen
Journal:  J Gastrointest Surg       Date:  2015-10-07       Impact factor: 3.452

Review 7.  Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy.

Authors:  Jonathan Athayde; Sarah C Davies; Claire E Parker; Leonardo Guizzetti; Christopher Ma; Reena Khanna; Brian G Feagan; Vipul Jairath
Journal:  Dig Dis Sci       Date:  2018-07-11       Impact factor: 3.199

8.  Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes.

Authors:  Shintaro Akiyama; Jacob E Ollech; Victoria Rai; Laura R Glick; Yangtian Yi; Cindy Traboulsi; Joseph Runde; Russell D Cohen; Kinga B Skowron; Roger D Hurst; Konstantin Umanskiy; Benjamin D Shogan; Neil H Hyman; Michele A Rubin; Sushila R Dalal; Atsushi Sakuraba; Joel Pekow; Eugene B Chang; David T Rubin
Journal:  Clin Gastroenterol Hepatol       Date:  2021-02-05       Impact factor: 11.382

9.  Factors affecting pouch-related outcomes after restorative proctocolectomy.

Authors:  Gyoung Tae Noh; Jeonghee Han; Min Soo Cho; Hyuk Hur; Byung Soh Min; Kang Young Lee; Nam Kyu Kim
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 10.  Chronic Antibiotic-Refractory Pouchitis: Management Challenges.

Authors:  An Outtier; Marc Ferrante
Journal:  Clin Exp Gastroenterol       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.